Our Commitment to Safety Communication
Verified safety updates from ongoing ocrelizumab clinical trials and post-marketing experience
Indications vary in different countries. The local prescribing information from your country is the primary source of information on the known and potential risks associated with ocrelizumab.
More than 70,000 patients with RMS or PPMS have started ocrelizumab globally.1
The following ocrelizumab global safety updates are available. Click below to learn more:
Updated Safety Analysis
Additional Topics of Interest
Post-marketing Commitments
Indication:
Indications vary in different countries. Please contact your local Roche Affiliate for more information on ocrelizumab.
References
- Roche data on file. October 2018
All Countries
Select a Country
Australia
Brazil
Domincan Republic
Finland
Germany
Kuwait
Norway
Qatar
Sweden
Switzerland / Lichtenstein
Turkey
United Arab Emirates
Australia
Roche Products Pty Limited
Level 8, 30-34 Hickson Road
Sydney NSW 2000 Australia
Tel: +61 2 9454 9444
+61 29454 90002
Fax: +61 2 9971 7401
Brazil
Produtos Roche Químicos e Farmacêuticos S.A.
Av. Engenheiro Billings, 1729
05321-900 São Paulo
Tel: +0800-7720-289 (Call Center)
Domincan Republic
Productos Roche Dominicana S.R.L.
Av. Winston Churchill Esq.
Paseo de los Locutores Plaza las Americas II
Local Y 28 B
Santo Domingo, D.N.
cac.farmacovigilancia@roche.com (Costa Rica sub-region)
download PI
Finland
Roche Oy
Klovinpellontie 3, PO Box 12
02180 Espoo
Finland
Tel: + 358 10 554 500
Germany
Roche Pharma AG
Emil-Barell-Str. 1
79639 Grenzach-Wyhlen
Tel: +497624 14 2869
Kuwait
Gulf Safety Unit
Cairo Festival City, Business Park A, Building A2, 4th Floor, Fifth Settlement
11835, Cairo, Egypt
Mobile: +20 1271400006
Norway
Roche Norge AS Brynsengfaret
6 B, 0667 Oslo
Postboks 6610
Etterstad, 0607 Oslo
Tel: +47 22789000
norway.drug_safety@roche.com
pharma.norge@roche.com
View SmPC
Qatar
Gulf Safety Unit
Cairo Festival City, Business Park A, Building A2, 4th Floor, Fifth Settlement
11835, Cairo, Egypt
Mobile: +20 1271400006
Sweden
Roche AB Box 1228
S-171 23 Solna
Tel: + 46 (0) 8 726 12 00
Fax: + 46 (0) 8 744 06 81
Switzerland / Lichtenstein
Roche Pharma (Schweiz) AG
Schoenmattstr. 2
4153 Reinach
Fax: +41 61 815 28 45
Turkey
Uniq İstanbul, Ayazağa Cad. No.4
D/101
Maslak 34396 Sarıyer-İstanbul
Tel: +90 212 366 90 00
United Arab Emirates
Medical Department Hoffmann-La Roche Ltd.
Galleries Buildings NO4, Floor 5, Jabel Ali Downtown
P.O. Box 27309
Dubai, UAE
Tel: +971 48164895
Mobile: +971 (0)54 440 9415
Fax: +971 4 8800212